UBS Maintains Neutral on Corteva, Lowers Price Target to $85

Corteva Inc

Corteva Inc

CTVA

0.00

UBS analyst Joshua Spector maintains Corteva (NYSE: CTVA) with a Neutral and lowers the price target from $89 to $85.